Systemic immune aberrations in ALS patients include alterations in macrophage activation profiles [41], [42], elevated levels of complement proteins in sera [50], increased IL-13 producing T cells and circulating neutrophils [51], [52], lymphopenia with reduced number of CD2+ and CD8+ T cells [53]. Here, VTN is linked to amyotrophic lateral sclerosis.